Telomere length of various blood and bone marrow cells in patients with aplastic anemia

   Background. Aplastic anemia proceeds with bone marrow failure and is associated with immunological suppression of normal blood stem cells’ proliferation, which lead to bone marrow aplasia. autoimmune aggression and internal defects of blood stem cell that cause abnormal hematopoiesis are being actively studied. An important role in the pathogenesis of the aplastic anemia is played by instability of telomere length (TL). determination of the initial TL makes it possible to clearly differentiate between the aplastic anemia and dyskeratosis congenita. also, it helps to identify the group of patients with short telomeres for prediction of therapy response.

   Aim. To investigation the TL of various blood and bone marrow cells in patients with aplastic anemia before treatment.

   Materials and methods. The group of patients with aplastic anemia was investigated (n = 45). blood donors (n = 32) and bone marrow donors (n = 10) of different ages were included in the reference group. adult patients with dyskeratosis congenita (n = 5) were included in the comparison group. Relative and absolute tl was identified in peripheral blood and bone marrow mononuclear cells, monocytes, lymphocytes by flow-FISH technique (combination of flow cytometry and fluorescence in situ hybridization).

   Results. Relative and absolute TL was comparable in different blood and bone marrow cells in patients with aplastic anemia before treatment. TL in peripheral blood and bone marrow mononuclear cells wasn’t significantly differed in groups of patients with aplastic anemia and healthy donors. Telomeres in patients with dyskeratosis congenita were identified as “ultrashort” and were significantly shorter than in patients with aplastic anemia.

   Conclusion. Determination of TL in patients with aplastic anemia is modern examination method, which is a necessary step of differential diagnosis between aplastic anemia and dyskeratosis congenita, which is the disease from group of constitutional bone marrow aplasia. It is preferred to identify the TL in adult patients with aplastic anemia by the flow-FISH. It is necessary to investigate the TL to predict treatment response and to identify risks of developing adverse experiences, which include relapse and clonal evolution.

1. Mihailova E.A., Fidarova Z.T., Troitskaya V.V. et al. Clinical recommendations for the diagnosis and treatment of aplastic anemia (2019 edition). Gematologiya i transfuziologiya = Russian Journal of Hematology and Transfusiology 2020;65(2):208–26. (In Russ.). DOI: 10.35754/0234-5730-2020-65-2-208-226

2. Shah Y.B., Priore S.F., Li Y.T. et al. The predictive value of PNH clones, 6p CN­LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis. Blood 2021;5(16):3216–26. DOI: 10.1182/BLOODADVANCES.2021004201

3. Scheinberg P. Acquired severe aplastic anaemia: how medical therapy evolved in the 20^th and 21^st centuries. Br J Haematol 2021;194(6):954–69. DOI: 10.1111/BJH.17403

4. Abramova A.V., Galtseva I.V., Mikhailova E.A. et al. Oligoclonality and subpopulation structure of bone marrow T­-cells in patients with aplastic anaemia. Gematologiya i transfuziologiya = Russian Journal of Hematology and Transfusiology 2020;65(4):417–30. (In Russ.). DOI: 10.35754/0234-5730-2020-65-4-417-430

5. Fidarova Z.T., Abramova A.V., Luchkin A.V. Clone of paroxysmal nocturnal haemoglobinuria and other predictors of the response to immunosuppressive therapy in patients with idiopathic aplastic anaemia. Gematologiya i transfuziologiya = Russian Journal of Hematology and Transfusiology 2019;64(3):342–52. (In Russ.). DOI: 10.35754/0234-5730-2019-64-3-342-352

6. Calado R.T., Cooper J.N., Padilla­Nash H.M. et al. Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia 2012;26(4):700–7. DOI: 10.1038/leu.2011.272

7. Scheinberg P. Prognostic value of telomere attrition in patients with aplastic anemia. Int J Hematol 2013;97(5):553–7. DOI: 10.1007/s12185-013-1332-x

8. Miwata S., Narita A., Okuno Y. et al. Clinical diagnostic value of telomere length measurement in inherited bone marrow failure syndromes. Haematologica 2021;106(9):2511. DOI: 10.3324/HAEMATOL.2021.278334

9. Gramatges M.M., Bertuch A.A. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res 2013;162(6):353–63. DOI: 10.1016/j.trsl.2013.05.003

10. Savage S.A., Alter B.P. Dyskeratosis congenita. Hematol Oncol Clin North Am 2009;23(2):215. DOI: 10.1016/J.HOC.2009.01.003

11. Brümmendorf T.H., Maciejewski J.P., Mak J. et al. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood 2001;97(4):895–900. DOI: 10.1182/BLOOD.V97.4.895

12. Kulagin A., Borisov V., Pronkina N. et al. Long­term outcomes of accelerated telomere shortening in acquired aplastic anemia. Blood 2014;124(21):4396. DOI: 10.1182/BLOOD.V124.21.4396.4396

13. Park H.S., Park S.N., Im K. et al. Telomere length and somatic mutations in correlation with response to immunosuppressive treatment in aplastic anaemia. Br J Haematol 2017;178(4):603–15. DOI: 10.1111/BJH.14691

14. Scheinberg P., Cooper J.N., Sloand E.M. et al. Association of telomere length of peripheral blood leukocytes with hemato poietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA 2010;304(12):1358–64. DOI: 10.1001/jama.2010.1376

15. Narita A., Muramatsu H., Sekiya Y. et al. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immuno suppressive therapy in pediatric aplastic anemia. Haematologica 2015;100(12):1546–52. DOI: 10.3324/haematol.2015.132530

16. Gutierrez­Rodrigues F., Santana­Lemos B.A., Scheucher P.S. et al. Direct comparison of flow­FISH and qPCR as diagnostic tests for telomere length measurement in humans. PLoS One 2014;9(11):e113747. DOI: 10.1371/JOURNAL.PONE.0113747

17. Sakoff J.A., de Waal E., Esther M.B. et al. Telomere length in haemopoietic stem cells can be determined from that of mononuclear blood cells or whole. Blood 2009;43(10):2017–20. DOI: 10.1080/1042819021000015970

18. Galtseva I.V., Philipenko M.L., Davydova Yu.O. et al. Сomparison of polymerase chain reaction and flow cytometry for measuring telomere length of human leukocytes. Klinicheskaia laboratornaia diagnostika = Clinical Laboratory Diagnostics 2021;66(3):154–9. (In Russ.). URL: https://elibrary.ru/item.asp?id=44890265&ysclid=lmg19vsd3y369418258

19. Roelofs H., de Pauw E., Zwinderman A.H. et al. Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation. Blood 2003;101(1):358–62. DOI: 10.1182/blood-2002-06-1832